A Phase 1b Study of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis
| Status: | Completed |
|---|---|
| Conditions: | Arthritis |
| Therapuetic Areas: | Rheumatology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 8/30/2018 |
| Start Date: | May 12, 2016 |
| End Date: | August 9, 2018 |
A Phase 1b Randomized, Double-blind, Placebo-controlled Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics, and Clinical Response of MEDI4920 in Subjects With Adult-onset Rheumatoid Arthritis
The purpose of this study is to determine whether MEDI4920 is safe and tolerable in patients
with adult-onset rheumatoid arthritis.
with adult-onset rheumatoid arthritis.
Inclusion Criteria:
- adult-onset rheumatoid arthritis
- swollen and tender joints
Exclusion Criteria:
- venous thromboembolism or arterial thrombosis
- pregnant or breastfeeding
- hepatitis B, C or HIV
- active or untreated latent tuberculosis
We found this trial at
9
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials